Cargando…
Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis
BACKGROUND: Current guidelines recommend psychological support for patients with pulmonary hypertension suffering from psychological adversity. However, little is known about the prevalence and risk factors of depression and anxiety in patients with pulmonary hypertension (PH). METHODS: Medline and...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892950/ https://www.ncbi.nlm.nih.gov/pubmed/35252232 http://dx.doi.org/10.3389/fmed.2022.765461 |
_version_ | 1784662283025121280 |
---|---|
author | Mai, Aaron Shengting Lim, Oliver Zi Hern Ho, Yeung Jek Kong, Gwyneth Lim, Grace En Hui Ng, Cheng Han Ho, Cyrus Ho, Roger Lim, Yinghao Kuntjoro, Ivandito Tay, Edgar Yip, James Chew, Nicholas W. S. Low, Ting-Ting |
author_facet | Mai, Aaron Shengting Lim, Oliver Zi Hern Ho, Yeung Jek Kong, Gwyneth Lim, Grace En Hui Ng, Cheng Han Ho, Cyrus Ho, Roger Lim, Yinghao Kuntjoro, Ivandito Tay, Edgar Yip, James Chew, Nicholas W. S. Low, Ting-Ting |
author_sort | Mai, Aaron Shengting |
collection | PubMed |
description | BACKGROUND: Current guidelines recommend psychological support for patients with pulmonary hypertension suffering from psychological adversity. However, little is known about the prevalence and risk factors of depression and anxiety in patients with pulmonary hypertension (PH). METHODS: Medline and Embase were searched from inception to 6 May 2021. Meta-analysis of proportions using the generalized linear mixed model was conducted to analyze the pooled prevalence rates of depression and anxiety in PH patients. Risk factors for depression and anxiety in PH patients were evaluated using meta regression. RESULTS: A total of 24 studies involving 2,161 PH patients were included. The pooled prevalence of depression in PH was 28.0% (95% CI: 20.5–36.8) and pooled prevalence of anxiety was 37.1% (95% CI: 28.7–46.4). There was a significantly higher prevalence of anxiety (p = 0.0013) amongst PH patients in Asia (61.1%) compared to Europe (40.3%) and North America (22.9%). In terms of risk factors, congenital heart disease-related pulmonary arterial hypertension (PAH-CHD) were significantly associated with both depression (OR: 1.68, 95% CI: 1.27–2.23, p = 0.024) and anxiety (OR: 1.63, 95% CI: 1.45–1.83, p = 0.002). On the other hand, chronic thromboembolic pulmonary hypertension (CTEPH, OR: 1.18, 95% CI: 1.10–1.26, p = 0.004) was significantly associated with depression, whereas worse pulmonary vascular resistance (β: 0.30, 95% CI: 0.09–0.52, p = 0.005) and cardiac index (β: −0.96, 95% CI: −1.58 to −0.35, p = 0.002) were significantly correlated with anxiety. CONCLUSION: The prevalence of anxiety and depression in PH patients is alarmingly high, with an increased prevalence of anxiety in Asia compared to Europe or North America. Psychological support is warranted for patients with PH, particularly those with underlying congenital heart disease, CTEPH, and severe disease. SYSTEMATIC REVIEW REGISTRATION: CRD42021251733. |
format | Online Article Text |
id | pubmed-8892950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88929502022-03-04 Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis Mai, Aaron Shengting Lim, Oliver Zi Hern Ho, Yeung Jek Kong, Gwyneth Lim, Grace En Hui Ng, Cheng Han Ho, Cyrus Ho, Roger Lim, Yinghao Kuntjoro, Ivandito Tay, Edgar Yip, James Chew, Nicholas W. S. Low, Ting-Ting Front Med (Lausanne) Medicine BACKGROUND: Current guidelines recommend psychological support for patients with pulmonary hypertension suffering from psychological adversity. However, little is known about the prevalence and risk factors of depression and anxiety in patients with pulmonary hypertension (PH). METHODS: Medline and Embase were searched from inception to 6 May 2021. Meta-analysis of proportions using the generalized linear mixed model was conducted to analyze the pooled prevalence rates of depression and anxiety in PH patients. Risk factors for depression and anxiety in PH patients were evaluated using meta regression. RESULTS: A total of 24 studies involving 2,161 PH patients were included. The pooled prevalence of depression in PH was 28.0% (95% CI: 20.5–36.8) and pooled prevalence of anxiety was 37.1% (95% CI: 28.7–46.4). There was a significantly higher prevalence of anxiety (p = 0.0013) amongst PH patients in Asia (61.1%) compared to Europe (40.3%) and North America (22.9%). In terms of risk factors, congenital heart disease-related pulmonary arterial hypertension (PAH-CHD) were significantly associated with both depression (OR: 1.68, 95% CI: 1.27–2.23, p = 0.024) and anxiety (OR: 1.63, 95% CI: 1.45–1.83, p = 0.002). On the other hand, chronic thromboembolic pulmonary hypertension (CTEPH, OR: 1.18, 95% CI: 1.10–1.26, p = 0.004) was significantly associated with depression, whereas worse pulmonary vascular resistance (β: 0.30, 95% CI: 0.09–0.52, p = 0.005) and cardiac index (β: −0.96, 95% CI: −1.58 to −0.35, p = 0.002) were significantly correlated with anxiety. CONCLUSION: The prevalence of anxiety and depression in PH patients is alarmingly high, with an increased prevalence of anxiety in Asia compared to Europe or North America. Psychological support is warranted for patients with PH, particularly those with underlying congenital heart disease, CTEPH, and severe disease. SYSTEMATIC REVIEW REGISTRATION: CRD42021251733. Frontiers Media S.A. 2022-02-17 /pmc/articles/PMC8892950/ /pubmed/35252232 http://dx.doi.org/10.3389/fmed.2022.765461 Text en Copyright © 2022 Mai, Lim, Ho, Kong, Lim, Ng, Ho, Ho, Lim, Kuntjoro, Tay, Yip, Chew and Low. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Mai, Aaron Shengting Lim, Oliver Zi Hern Ho, Yeung Jek Kong, Gwyneth Lim, Grace En Hui Ng, Cheng Han Ho, Cyrus Ho, Roger Lim, Yinghao Kuntjoro, Ivandito Tay, Edgar Yip, James Chew, Nicholas W. S. Low, Ting-Ting Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis |
title | Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis |
title_full | Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis |
title_fullStr | Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis |
title_full_unstemmed | Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis |
title_short | Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis |
title_sort | prevalence, risk factors and intervention for depression and anxiety in pulmonary hypertension: a systematic review and meta-analysis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892950/ https://www.ncbi.nlm.nih.gov/pubmed/35252232 http://dx.doi.org/10.3389/fmed.2022.765461 |
work_keys_str_mv | AT maiaaronshengting prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT limoliverzihern prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT hoyeungjek prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT konggwyneth prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT limgraceenhui prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT ngchenghan prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT hocyrus prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT horoger prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT limyinghao prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT kuntjoroivandito prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT tayedgar prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT yipjames prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT chewnicholasws prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis AT lowtingting prevalenceriskfactorsandinterventionfordepressionandanxietyinpulmonaryhypertensionasystematicreviewandmetaanalysis |